Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 13, 2015

Study Completion Date

August 13, 2015

Conditions
Alzheimer's Disease
Interventions
DRUG

CERE-110: Adeno-Associated Virus injection Surgery

Injecting CERE-110 2.0 X 10\^11 vg into brain during surgical procedure.

PROCEDURE

Placebo Surgery

Placebo Surgery

Trial Locations (10)

10029

Mount Sinai School of Medicine, New York

20007

Georgetown University, Washington D.C.

27710

Duke University, Durham

29406

Medical University of South Carolina, North Charleston

30325

Emory University, Atlanta

35294

University of Alabama, Birmingham

44120

Case Western Reserve University, Cleveland

84108

University of Utah, Salt Lake City

90095

University of California, Los Angeles, Los Angeles

92037

University of California, San Diego, San Diego

Sponsors
All Listed Sponsors
collaborator

Alzheimer's Disease Cooperative Study (ADCS)

OTHER

lead

Sangamo Therapeutics

INDUSTRY